Dermata Therapeutics Holdings

DRMAW

Attention (50-day avg)0%

Attention rank (50-day avg)#5,007

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization10.5K

Earnings per share-2.16

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)-7.6M

Social

What share of all stock conversation is about DRMAW?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% new	0% 0

Sentiment

Of the messages about DRMAW that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	—
Bearish	—	—	—	—

Topics

Of the messages about DRMAW that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	32.91%
Announcements	—	—	—	38.46%
Controversies	—	—	—	0%
Earnings	—	—	—	0%
Macro	—	—	—	28.63%
Technical Analysis	—	—	—	0%

Community

Of the messages about DRMAW, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	0%	0.87%
Newcomers	—	—	100%	99.13%

SAN DIEGO, CA / ACCESS Newswire / August 25, 2026 / Dermata Therapeutics, Inc. (Nasdaq:DRMA) ("Dermata," or the "Company"), a science-driven leader in dermatologic solutions, today announced the official commercial launch of the Tome Foundational Treatment, the first product available for purchase under the Company's Tome skincare brand. The Foundational Treatment is now available for immediate purchase at www.tomeskincare.com, either as a one-time purchase or through a monthly subscription at a discounted price. The commercial launch marks a significant landmark in Dermata's evolution into a direct-to-consumer skincare company and represents the Company's first commercial product under the Tome brand.

1mo agoYahoo Finance

Dermata opens preorders for Tome skincare product

1mo agoInvesting.com

Dermata Announces Preorders Now Open for Tome Foundational Treatment Ahead of Commercial Launch

- Preorders can be made by visiting www.tomeskincare.com - - Dermata is ready to begin shipping orders on the expected launch date of August 25, 2026 - - Tome Foundational Treatment is a once-weekly topical mask for skin renewal - SAN DIEGO, CA / ...

1mo agoYahoo Finance

Dermata Therapeutics raises $3.4 million in private placement

1mo agoInvesting.com

Also Discussed

Investors talking about DRMAW also mention

#	Name	Attention
1	Dermata Therapeutics, Inc.DRMA	0%new
2	Esh Acquisition Corp.ESHA	0%0
3	Alchemy Investments Acquisition Corp.ALCY	0%0
4	ULY - Urgent.ly Inc. Common Stock	——
5	Anghami Inc.ANGHW	0%new
6	Modular Medical, Inc.MODD	0%+0
7	UTime LimitedWTO	0%0
8	Fitell Corp.FTEL	0%0
9	BSLK - Bolt Projects Holdings, Inc.	——
10	OSR Health, Inc.OSRH	0.01%+0

Dermata Therapeutics Holdings Inc.

Healthcare
Biotechnology

Dermata Therapeutics Holdings Inc. is a clinical-stage biotechnology company dedicated to developing and commercializing novel pharmaceutical products. Its primary focus is on treating medical dermatological conditions with significant market needs. The company's distinctive approach involves leveraging its proprietary platform targeting both inflammatory mechanisms and tissue remodeling, leading to potential therapeutic breakthroughs. Dermata's pipeline includes innovative treatments for a variety of skin disorders, designed to offer improved efficacy over existing solutions. Through strategic partnerships and ongoing clinical research, Dermata aims to address challenging diseases like psoriasis and acne, which impact millions worldwide. Its commitment to innovation positions it as a significant player in the biotechnology industry, potentially transforming the dermatological treatment landscape.

Website

Location

3525 Del Mar Heights Rd.

San Diego, CA, 92130

United States

Social

What share of all stock conversation is about DRMAW?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% new	0% 0

Sentiment

Of the messages about DRMAW that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	—
Bearish	—	—	—	—

Topics

Of the messages about DRMAW that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	32.91%
Announcements	—	—	—	38.46%
Controversies	—	—	—	0%
Earnings	—	—	—	0%
Macro	—	—	—	28.63%
Technical Analysis	—	—	—	0%

Community

Of the messages about DRMAW, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	0%	0.87%
Newcomers	—	—	100%	99.13%

Dermata Therapeutics Holdings

Social

Sentiment

Topics

Community

News

12 Health Care Stocks Moving In Tuesday's After-Market Session

Dermata launches first direct-to-consumer skincare product

Dermata Therapeutics Announces Commercial Launch of Tome Foundational Treatment

Dermata opens preorders for Tome skincare product

Dermata Announces Preorders Now Open for Tome Foundational Treatment Ahead of Commercial Launch

Dermata Therapeutics raises $3.4 million in private placement

Also Discussed

Dermata Therapeutics Holdings Inc.

Company Information

Location

News

12 Health Care Stocks Moving In Tuesday's After-Market Session

Dermata launches first direct-to-consumer skincare product

Dermata Therapeutics Announces Commercial Launch of Tome Foundational Treatment

Dermata opens preorders for Tome skincare product

Dermata Announces Preorders Now Open for Tome Foundational Treatment Ahead of Commercial Launch

Dermata Therapeutics raises $3.4 million in private placement

Also Discussed

Social

Sentiment

Topics

Community